...
首页> 外文期刊>Internal medicine journal >Substantial variation in post-engraftment infection prophylaxis and revaccination practice in autologous stem cell transplant patients
【24h】

Substantial variation in post-engraftment infection prophylaxis and revaccination practice in autologous stem cell transplant patients

机译:自体干细胞移植患者移植后感染预防和重新接种实践的显着差异

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

There is a paucity of evidence supporting the necessity or duration of Pneumocystis jirovecii and antiviral prophylaxis as well as revaccination following autologous stem cell transplant (ASCT). A survey aimed at evaluating these policies was distributed to 34 ASCT centres across Australasia. The 26 survey respondents demonstrated significant heterogeneity in their infection prophylaxis and revaccination strategy post-transplant despite the availability of consensual guidelines.
机译:缺乏证据支持自发性干细胞移植(ASCT)后需进行吉氏肺孢子菌,抗病毒预防以及再次接种的必要性或持续时间。旨在评估这些政策的调查已分发给整个澳大拉西亚的34个ASCT中心。尽管有双方同意的指南,但26位接受调查的受访者在移植后的感染预防和再接种策略上显示出显着的异质性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号